Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP). (Q43517336)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP). |
scientific article |
Statements
Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP) (English)
H Fensterer
C Schade-Brittinger
H-H Müller
S Tebbe
J Fass
U Lindig
U Settmacher
W E Schmidt
A Märten
M P Ebert
M Kornmann
R Hofheinz
E Endlicher
C Brendel
P J Barth
D K Bartsch
P Michl
Arbeitsgemeinschaft Internistische Onkologie